Cargando…
Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department
Background and Objectives: Polypharmacy heavily impacts the quality of life of patients worldwide. It is a necessary evil in many disorders, and especially in type 2 diabetes mellitus, as patients require treatment both for this condition and its related or unrelated comorbidities. Thus, we aimed to...
Autores principales: | Dobrică, Elena-Codruța, Găman, Mihnea-Alexandru, Cozma, Matei-Alexandru, Bratu, Ovidiu Gabriel, Pantea Stoian, Anca, Diaconu, Camelia Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723949/ https://www.ncbi.nlm.nih.gov/pubmed/31382651 http://dx.doi.org/10.3390/medicina55080436 |
Ejemplares similares
-
Dyslipidemia: A Trigger for Coronary Heart Disease in Romanian Patients with Diabetes
por: Găman, Mihnea-Alexandru, et al.
Publicado: (2020) -
Polypharmacy in the Management of Arterial Hypertension—Friend or Foe?
por: Diaconu, Camelia Cristina, et al.
Publicado: (2021) -
Implications of Type 2 Diabetes Mellitus in Patients with Acute Cholangitis: A Systematic Review of Current Literature
por: Cozma, Matei-Alexandru, et al.
Publicado: (2022) -
Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
por: Găman, Mihnea-Alexandru, et al.
Publicado: (2021) -
Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review
por: Găman, Mihnea-Alexandru, et al.
Publicado: (2021)